VIRS
Pacer BioThreat Strategy ETF
VIRS
VIRS
Delisted
VIRS was delisted on the 10th of October, 2024.
5 hedge funds and large institutions have $489K invested in Pacer BioThreat Strategy ETF in 2021 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
5
Holders Change
+1
Holders Change %
+25%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
+$4K |
Top Sellers
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$1.31M |
| 2 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
-$50.8K |
| 3 |
HI
Harbour Investments
Madison,
Wisconsin
|
-$18K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Cambridge Investment Research Advisors
Fairfield,
Iowa
| $247K | -$50.8K | -1,599 | -17% |
|
|
2
Royal Bank of Canada
Toronto,
Ontario, Canada
| $176K | -$1.31M | -41,281 | -88% |
|
3
Osaic Holdings
Scottsdale,
Arizona
| $62K | – | – | – |
|
|
4
UBS Group
Zurich,
Switzerland
| $4K | +$4K | +123 | New |
|
|
HI
5
Harbour Investments
Madison,
Wisconsin
| – | -$18K | -608 | Closed |
|